U.S. Markets open in 2 hrs 10 mins

Navidea Biopharmaceuticals, Inc (NAVB)

NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.4435-0.02 (-3.67%)
At close: 4:02PM EDT
People also watch
Interactive chart
Previous Close0.4604
Bid0.4375 x 1000
Ask0.4700 x 1000
Day's Range0.4400 - 0.4698
52 Week Range0.2600 - 1.1600
Avg. Volume772,276
Market Cap71.71M
PE Ratio (TTM)0.93
EPS (TTM)0.48
Earnings DateMar 24, 2017 - Mar 27, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.25
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents7 days ago

    Edited Transcript of NAVB earnings conference call or presentation 10-May-17 12:00pm GMT

    Q1 2017 Navidea Biopharmaceuticals Inc Earnings Call

  • American City Business Journals8 days ago

    Navidea pays former CEO $618,000 after losing arbitration over his firing

    Navidea Biopharmaceuticals Inc. paid $617,880 to former CEO Rick Gonzalez on Tuesday after an arbitrator in a blistering ruling said the company fired him without cause one year ago . The payment represented a $518,000 severance and bonus award, plus interest and costs, which was then reduced by salary and unused vacation paid to Gonzalez at his departure, the company said in a filing with the U.S. Securities and Exchange Commission. The arbitration decision can't be appealed.

  • Associated Press16 days ago

    Navidea posts 1Q profit

    The Dublin, Ohio-based company said it had profit of 52 cents per share. Losses, adjusted to account for discontinued operations, came to 1 cent per share. The biopharmaceutical posted revenue of $580,000 ...